Literature DB >> 33825700

Structural biology of coronavirus ion channels.

Francisco J Barrantes1.   

Abstract

Viral infection compromises specific organelles of the cell and readdresses its functional resources to satisfy the needs of the invading body. Around 70% of the coronavirus positive-sense single-stranded RNA encodes proteins involved in replication, and these viruses essentially take over the biosynthetic and transport mechanisms to ensure the efficient replication of their genome and trafficking of their virions. Some coronaviruses encode genes for ion-channel proteins - the envelope protein E (orf4a), orf3a and orf8 - which they successfully employ to take control of the endoplasmic reticulum-Golgi complex intermediate compartment or ERGIC. The E protein, which is one of the four structural proteins of SARS-CoV-2 and other coronaviruses, assembles its transmembrane protomers into homopentameric channels with mild cationic selectivity. Orf3a forms homodimers and homotetramers. Both carry a PDZ-binding domain, lending them the versatility to interact with more than 400 target proteins in infected host cells. Orf8 is a very short 29-amino-acid single-passage transmembrane peptide that forms cation-selective channels when assembled in lipid bilayers. This review addresses the contribution of biophysical and structural biology approaches that unravel different facets of coronavirus ion channels, their effects on the cellular machinery of infected cells and some structure-functional correlations with ion channels of higher organisms.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronaviruses; cryo-electron microscopy; structure–function correlations; viral ion channels; viroporins

Year:  2021        PMID: 33825700     DOI: 10.1107/S2059798321001431

Source DB:  PubMed          Journal:  Acta Crystallogr D Struct Biol        ISSN: 2059-7983            Impact factor:   7.652


  4 in total

1.  Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds.

Authors:  M O Koifman; A S Malyasova; Yu V Romanenko; E S Yurina; N Sh Lebedeva; Yu A Gubarev; O I Koifman
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2022-05-17       Impact factor: 4.831

Review 2.  SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.

Authors:  Evgenii Gusev; Alexey Sarapultsev; Liliya Solomatina; Valeriy Chereshnev
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

3.  An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2.

Authors:  Sk Sarif Hassan; Vaishnavi Kodakandla; Elrashdy M Redwan; Kenneth Lundstrom; Pabitra Pal Choudhury; Tarek Mohamed Abd El-Aziz; Kazuo Takayama; Ramesh Kandimalla; Amos Lal; Ángel Serrano-Aroca; Gajendra Kumar Azad; Alaa A A Aljabali; Giorgio Palù; Gaurav Chauhan; Parise Adadi; Murtaza Tambuwala; Adam M Brufsky; Wagner Baetas-da-Cruz; Debmalya Barh; Vasco Azevedo; Nikolas G Bazan; Bruno Silva Andrade; Raner José Santana Silva; Vladimir N Uversky
Journal:  PeerJ       Date:  2022-03-21       Impact factor: 2.984

4.  Electrostatic Map of the SARS-CoV-2 Virion Specifies Binding Sites of the Antiviral Cationic Photosensitizer.

Authors:  Vladimir Fedorov; Ekaterina Kholina; Sergei Khruschev; Ilya Kovalenko; Andrew Rubin; Marina Strakhovskaya
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.